Skip to main content

Table 3 Acute and late toxicity from different studies

From: High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients

Authors

Acute toxicity

Late toxicity

 

GU (%)

GI (%)

GU (%)

GI (%)

 

Grade

Grade

Grade

Grade

 

2

3

4

2

3

4

2

3

4

2

3

4

3D-conformal radiotherapy

            

   Storey, 2000 [18], Pollack 2002 [2]

24

4

1

43

0

0

10

3

-

19

7

-

   Beckendorf, 2004 [15]

30

7

-

28

2

-

-

-

-

-

-

-

   Michalski, 2005 [16]

41

3

0

41

3

0

17

4

0

18

2

1

   Zietman, 2005 [3]

49

1

1

57

0

0

20

1

0

17

1

0

   Peeters, 2005/2006 [1,17]

42

13

0

47

4

0

26

13

-

27

5

-

Intensity-modulated radiotherapy

            

   Zelefsky, 2002/2006 [8,11]

28

0.1

0

5

0

0

9

3

0

2

0.1

0

   De Meerleer, 2004/2007 [7,10]

36

7

0

29

0

0

19

3

0

17

1

0

   Teh, 2005 [23]

35

0

0

6

0

0

-

-

-

7

2

0

   Skala, 2007 [9]

-

-

-

-

-

-

9

1

-

3

1

-

   Current study

47

3

0

30

0

0

21

4

0.3

9

1

0.3

  1. Abbreviations: GU = genitourinary; GI = gastrointestinal; - = toxicity rate not available.